Entrectinib in NTRK fusion-positive sarcoma: integrated analysis of patients enrolled in STATRK-2, STARTRK-1 and ALKA-372-001J. Wolf,S. V. Liu, L. Paz-Ares,J. Hu,B. C. Cho, M. Krzakowski,C. H. Chung,M. Patel,M. Taylor, H. Zeuner,A. Aziez,X. Huang,S. Osborne, A. FaragoONCOLOGY RESEARCH AND TREATMENT（2020）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
